Stephen C. Hadler

13.7k total citations · 5 hit papers
136 papers, 8.5k citations indexed

About

Stephen C. Hadler is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Stephen C. Hadler has authored 136 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Epidemiology, 60 papers in Hepatology and 47 papers in Infectious Diseases. Recurrent topics in Stephen C. Hadler's work include Hepatitis B Virus Studies (59 papers), Hepatitis Viruses Studies and Epidemiology (44 papers) and Vaccine Coverage and Hesitancy (41 papers). Stephen C. Hadler is often cited by papers focused on Hepatitis B Virus Studies (59 papers), Hepatitis Viruses Studies and Epidemiology (44 papers) and Vaccine Coverage and Hesitancy (41 papers). Stephen C. Hadler collaborates with scholars based in United States, China and Switzerland. Stephen C. Hadler's co-authors include Harold S. Margolis, James E. Maynard, Miriam J. Alter, Beth P. Bell, Susan E. Reef, Fangjun Zhou, Susan T. Goldstein, Eric E. Mast, Clare A. Dykewicz and Lynette Phillips and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Stephen C. Hadler

135 papers receiving 7.9k citations

Hit Papers

Use of 13-Valent Pneumoc... 1986 2026 1999 2012 2014 2005 1986 2021 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen C. Hadler United States 46 5.6k 3.4k 2.5k 1.9k 646 136 8.5k
Kathleen M. Neuzil United States 52 8.1k 1.4× 1.5k 0.5× 4.9k 1.9× 2.3k 1.2× 515 0.8× 207 12.6k
Trudy V. Murphy United States 35 3.1k 0.6× 1.2k 0.3× 1.7k 0.7× 1.2k 0.6× 1.6k 2.5× 99 5.0k
Mel Krajden Canada 57 8.4k 1.5× 3.5k 1.0× 3.5k 1.4× 560 0.3× 395 0.6× 367 11.8k
H Whittle Gambia 54 3.9k 0.7× 1.6k 0.5× 1.8k 0.7× 852 0.5× 968 1.5× 138 7.3k
James E. Maynard United States 46 4.8k 0.8× 4.3k 1.3× 1.8k 0.7× 579 0.3× 241 0.4× 152 6.7k
Rafael Harpaz United States 40 5.1k 0.9× 739 0.2× 1.3k 0.5× 1.3k 0.7× 346 0.5× 95 6.9k
Pier Luigi Lopalco Italy 41 2.6k 0.5× 927 0.3× 1.3k 0.5× 1.5k 0.8× 334 0.5× 193 4.6k
Walter A. Orenstein United States 58 6.8k 1.2× 561 0.2× 3.8k 1.5× 5.2k 2.8× 810 1.3× 305 12.4k
Carolyn B. Bridges United States 58 13.6k 2.4× 701 0.2× 4.2k 1.7× 4.4k 2.3× 709 1.1× 139 17.0k
Lisa A. Grohskopf United States 39 5.9k 1.1× 472 0.1× 3.0k 1.2× 2.3k 1.2× 636 1.0× 70 8.7k

Countries citing papers authored by Stephen C. Hadler

Since Specialization
Citations

This map shows the geographic impact of Stephen C. Hadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Hadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Hadler more than expected).

Fields of papers citing papers by Stephen C. Hadler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Hadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Hadler. The network helps show where Stephen C. Hadler may publish in the future.

Co-authorship network of co-authors of Stephen C. Hadler

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Hadler. A scholar is included among the top collaborators of Stephen C. Hadler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Hadler. Stephen C. Hadler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Levitan, Bennett, Stephen C. Hadler, William Hurst, et al.. (2023). The Brighton collaboration standardized module for vaccine benefit-risk assessment. Vaccine. 42(4). 972–986. 5 indexed citations
3.
Tan, Yi, Virasakdi Chongsuvivatwong, Xinghua Wu, et al.. (2015). A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007- June 2012. PLoS ONE. 10(12). e0144366–e0144366. 20 indexed citations
4.
Kane, M., et al.. (2013). The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization. Vaccine. 31. J15–J20. 37 indexed citations
5.
Liang, Xiaofeng, Fuqiang Cui, Stephen C. Hadler, et al.. (2013). Origins, design and implementation of the China GAVI project. Vaccine. 31. J8–J14. 30 indexed citations
6.
Wu, Zhenhua, Fuqiang Cui, Yuansheng Chen, et al.. (2013). Evaluation of immunization injection safety in China, 2010: Achievements, future sustainability. Vaccine. 31. J43–J48. 14 indexed citations
7.
Tuttle, Jessica, et al.. (1997). The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.. American Journal of Public Health. 87(12). 2045–2048. 50 indexed citations
9.
Chen, Robert T., John W. Glasser, Philip Rhodes, et al.. (1997). Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States. PEDIATRICS. 99(6). 765–773. 281 indexed citations
10.
LeBaron, Charles W., Guthrie S. Birkhead, John C. Grabau, et al.. (1996). Measles vaccination levels of children enrolled in WIC during the 1991 measles epidemic in New York City.. American Journal of Public Health. 86(11). 1551–1556. 11 indexed citations
11.
Birkhead, Guthrie S., Charles W. LeBaron, John C. Grabau, et al.. (1995). The immunization of children enrolled in the Special Supplemental Food Program for Women, Infants, and Children (WIC). The impact of different strategies.. PubMed. 274(4). 312–6. 53 indexed citations
12.
Wassilak, Steven G. F., et al.. (1995). Utility of Large‐linked Databases in Vaccine Safety, Particularly in Distinguishing Independent and Synergistic Effects. Annals of the New York Academy of Sciences. 754(1). 377–377. 35 indexed citations
13.
Cutts, Felicity T., et al.. (1993). Successes and Failures in Vaccine Delivery: Evaluation of the Immunization Delivery System in Puerto Rico. PEDIATRICS. 91(2). 315–320. 33 indexed citations
14.
Williams, Walter W., et al.. (1991). Hepatitis B vaccination programs for health care personnel in U.S. hospitals.. PubMed. 105(6). 610–6. 9 indexed citations
15.
Margolis, Harold S., Miriam J. Alter, & Stephen C. Hadler. (1991). Hepatitis B: Evolving Epidemiology and Implications for Control. Seminars in Liver Disease. 11(2). 84–92. 328 indexed citations
16.
Parish, David C., et al.. (1991). Immunogenicity of Low-Dose Intradermal Recombinant DNA Hepatitis B Vaccine. Southern Medical Journal. 84(4). 426–430. 14 indexed citations
17.
Mishu, Ban, et al.. (1990). Foodborne Hepatitis A: Evidence that Microwaving Reduces Risk?. The Journal of Infectious Diseases. 162(3). 655–658. 13 indexed citations
18.
Toukan, Ala U., et al.. (1990). THE EPIDEMIOLOGY OF HEPATITIS B VIRUS AMONG FAMILY MEMBERS IN THE MIDDLE EAST. American Journal of Epidemiology. 132(2). 220–232. 73 indexed citations
19.
Maynard, James E., Mark Kane, & Stephen C. Hadler. (1989). Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on Immunization. Clinical Infectious Diseases. 11(Supplement_3). S574–S578. 123 indexed citations
20.
Weisfuse, Isaac B., Stephen C. Hadler, Howard A. Fields, et al.. (1989). Delta hepatitis in homosexual men in the united states. Hepatology. 9(6). 872–874. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026